Clinical Trial Update: Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vincristine, dactinomycin, and cyclophosphamide with or without radiation therapy in newly diagnosed low-risk rhabdomyosarcoma; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Dactinomycin (dactinomycin)
• Radiation therapy
• Vincristine (vincristine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma | Phase 3 | Status: COMPLETED | Results posted: 2014-04-11